KLDO (Kaleido Biosciences) Common Stock: $0.04 Mil (As of Dec. 2021)


What is Kaleido Biosciences Common Stock?

Kaleido Biosciences KLDO -99.00% Common Stock is $0.04 Mil as of Dec. 2021.

Kaleido Biosciences's quarterly common stock stayed the same from Jun. 2021 ($0.04 Mil) to Sep. 2021 ($0.04 Mil) and stayed the same from Sep. 2021 ($0.04 Mil) to Dec. 2021 ($0.04 Mil).

Kaleido Biosciences's annual common stock increased from Dec. 2019 ($0.03 Mil) to Dec. 2020 ($0.04 Mil) and increased from Dec. 2020 ($0.04 Mil) to Dec. 2021 ($0.04 Mil).

Kaleido Biosciences Common Stock Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Common Stock Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Common Stock
Get a 7-Day Free Trial 0.01 0.01 0.03 0.04 0.04

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.04 0.04

Kaleido Biosciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.04 Mil mean?
Kaleido Biosciences (KLDO) has a Common Stock of $0.04 Mil as of Dec. 2021. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Common Stock too high?
Kaleido Biosciences' current Common Stock is $0.04 Mil.
How does Kaleido Biosciences' Common Stock compare to NPTX and GSTC?
Kaleido Biosciences' Common Stock of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kaleido Biosciences and its competitors. Kaleido Biosciences's current Common Stock is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Common Stock of $0.04 Mil. The current Common Stock is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Common Stock is $0.04 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.